Myocarditis in adult-onset Still's disease despite significant immunosuppressive therapy [5]

Scandinavian Journal of Rheumatology

Volumn 35, Issue 4, 2006, Pages 330-331

  Kristensen, L E ^a   Bartosik, I ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; ARTHRITIS; CASE REPORT; ELECTROCARDIOGRAM; FEVER; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MALE; MYALGIA; MYOCARDITIS; PRIORITY JOURNAL; SCINTIGRAPHY; TREATMENT OUTCOME;

ADULT; FIBROSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MYOCARDITIS; MYOCARDIUM; PREDNISOLONE; STILL'S DISEASE, ADULT-ONSET;

EID: 33746844885     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740500499492     Document Type: Letter

References (9)

1. Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set classification criteria for adult onset Still disease. Medicine (Baltimore) 2002;81:194-200.
2. Masson C, Le Loet X, Liote F, Renou P, Dubost JJ, Boissier MC, et al. Adult Still's disease: part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed 1995;62:748-57.
3. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
4. Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001;19:329-32.
5. Hosaka S, Takashina N, Ishikawa A, Kondo H, Kashiwazaki S. Adult Still's disease with myocarditis and peritonitis. Intern Med 1992;31:812-15.
6. Khanna D, McMahon M, Furst DE. Safety of tumor necrosis factor-alpha antagonists. Drug Safety 2004;27:307-24.
7. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104:39-45.
8. Parrillo JE. Inflammatory cardiomypathy (myocarditis): which patients should be treated with anti-inflammatory therapy? Circulation 2001;104:4-6.
9. Hia CPP, Yip WCL, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004;89:580-4.